Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 37
Filtrar
1.
Semin Fetal Neonatal Med ; 25(4): 101127, 2020 08.
Artigo em Inglês | MEDLINE | ID: mdl-32571668

RESUMO

Babies who sustain long term neurologic injury and disability are frequent subjects in medical malpractice litigation. In the United States, the tort system enables adjudication of claims through a proscribed system. This paper will review salient elements of the tort system-duty, breach, causation, and damages- and how they apply to encephalopathic infants whose injuries are believed to be the result of fetal inflammatory response syndrome (FIRS) and/or hypoxic-ischemic damage. FIRS may confound the diagnosis of neonatal encephalopathy but may be a credible explanation for it as well. The ways in which FIRS may impact malpractice lawsuits are presented.


Assuntos
Doenças do Prematuro/prevenção & controle , Responsabilidade Legal , Imperícia/legislação & jurisprudência , Cuidado Pré-Natal/legislação & jurisprudência , Síndrome de Resposta Inflamatória Sistêmica/prevenção & controle , Feminino , Feto , Humanos , Lactente , Erros Médicos/legislação & jurisprudência , Gravidez , Estados Unidos
2.
Obstet Gynecol ; 135(4): 994-995, 2020 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-32217975

RESUMO

The rapidly evolving genetic technologies that are available to patients and obstetrician-gynecologists have transformed the practice of clinical medicine. From cell-free DNA screening technologies in pregnancy to expanded carrier screening and hereditary cancer gene panels, obstetrician-gynecologists often are faced with questions about their legal responsibilities regarding genetic information as well as the legal ramifications of this information for their patients.The Committee on Genetics has constructed the following case studies to highlight some of the legal issues an obstetrician-gynecologist may encounter when performing genetic testing. These cases do not cover the breadth of legal issues affecting clinical genetics, but rather they illustrate certain legal concepts and principles as well as key pieces of legislation that are pertinent to clinical care. These case descriptions are not intended to serve as legal advice. Obstetrician-gynecologists are strongly encouraged to seek expert legal assistance to resolve questions involving legal rights or responsibilities.


Assuntos
Aconselhamento Genético/legislação & jurisprudência , Testes Genéticos/legislação & jurisprudência , Cuidado Pré-Natal/legislação & jurisprudência , Adulto , Feminino , Ginecologia , Humanos , Obstetrícia , Gravidez , Complicações na Gravidez/diagnóstico , Sociedades Médicas , Estados Unidos
3.
Obstet Gynecol ; 135(4): e189-e192, 2020 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-32217981

RESUMO

The rapidly evolving genetic technologies that are available to patients and obstetrician-gynecologists have transformed the practice of clinical medicine. From cell-free DNA screening technologies in pregnancy to expanded carrier screening and hereditary cancer gene panels, obstetrician-gynecologists often are faced with questions about their legal responsibilities regarding genetic information as well as the legal ramifications of this information for their patients.The Committee on Genetics has constructed the following case studies to highlight some of the legal issues an obstetrician-gynecologist may encounter when performing genetic testing. These cases do not cover the breadth of legal issues affecting clinical genetics, but rather they illustrate certain legal concepts and principles as well as key pieces of legislation that are pertinent to clinical care. These case descriptions are not intended to serve as legal advice. Obstetrician-gynecologists are strongly encouraged to seek expert legal assistance to resolve questions involving legal rights or responsibilities.


Assuntos
Aconselhamento Genético/legislação & jurisprudência , Testes Genéticos/legislação & jurisprudência , Cuidado Pré-Natal/legislação & jurisprudência , Adulto , Feminino , Ginecologia , Humanos , Obstetrícia , Gravidez , Complicações na Gravidez/diagnóstico , Sociedades Médicas , Estados Unidos
4.
Matern Child Health J ; 23(6): 756-767, 2019 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-30600519

RESUMO

Objective To measure the proportion of women screened for IPV during prenatal care; to assess the predictors of prenatal IPV screening. Methods We use the CDC's 2012 Pregnancy Risk Assessment Monitoring System, representative of births in 24 states and New York City (N = 28,581). We calculated descriptive and logistic regressions, weighted to deal with state-clustered observations. Results 49.2% of women in our sample reported being screened for IPV while pregnant. There were higher screening rates among women of color, and those who had not completed high school, never been married, received WIC benefits, initiated prenatal care in the first trimester, and were publicly insured. State screening rates varied (29.9-62.9%). Among states, mandated perinatal depression screening or training was positively associated with IPV screening. 3.6% of women in our sample reported prenatal IPV but were not screened during pregnancy. Conclusions for Practice Current efforts have not led to universal screening. We need to better understand when and why providers do not screen pregnant patients for IPV.


Assuntos
Seguro Saúde/estatística & dados numéricos , Violência por Parceiro Íntimo/estatística & dados numéricos , Programas de Rastreamento/estatística & dados numéricos , Grupos Raciais/estatística & dados numéricos , Maus-Tratos Conjugais/diagnóstico , Adolescente , Adulto , Feminino , Humanos , Cobertura do Seguro/estatística & dados numéricos , Violência por Parceiro Íntimo/legislação & jurisprudência , Programas de Rastreamento/legislação & jurisprudência , Serviços de Saúde Materna , Gravidez , Gestantes , Cuidado Pré-Natal/legislação & jurisprudência , Cuidado Pré-Natal/métodos , Fatores Socioeconômicos , Maus-Tratos Conjugais/estatística & dados numéricos , Estados Unidos/epidemiologia , Adulto Jovem
6.
Duke Law J ; 67(4): 827-62, 2018 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-29469554

RESUMO

In the United States, women are routinely forced to undergo cesarean sections, episiotomies, and the use of forceps, despite their desire to attempt natural vaginal delivery. Yet, the current American legal system does little to provide redress for women coerced to undergo certain medical procedures during childbirth. Courts and physicians alike are prepared to override a woman's choice of childbirth procedure if they believe this choice poses risks to the fetus, and both give little value to the woman's right to bodily autonomy. This Note proposes a solution for addressing the problem of coerced medical procedures during childbirth by importing a framework created in Venezuela and Argentina that characterizes this issue as "obstetric violence." First, this Note contains an overview of the shortcomings of the existing American legal framework to address the problem. Second, it explains the advantages of the obstetric violence framework and argues that its adoption in the United States would address many of the failures of the existing system. And third, this Note introduces a few legislative and litigation strategies that can be used to implement this framework in the United States and briefly addresses some of the challenges these strategies may pose.


Assuntos
Direitos Civis/legislação & jurisprudência , Coerção , Parto Obstétrico/legislação & jurisprudência , Episiotomia/legislação & jurisprudência , Violência de Gênero/legislação & jurisprudência , Violação de Direitos Humanos/legislação & jurisprudência , Procedimentos Cirúrgicos Obstétricos/efeitos adversos , Obstetrícia/legislação & jurisprudência , Parto , Autonomia Pessoal , Cuidado Pré-Natal/legislação & jurisprudência , Direitos Sexuais e Reprodutivos/legislação & jurisprudência , Recusa do Paciente ao Tratamento/legislação & jurisprudência , Violência/legislação & jurisprudência , Saúde da Mulher/legislação & jurisprudência , Direitos da Mulher/legislação & jurisprudência , Aborto Legal , Argentina , Feminino , Feto , Humanos , Consentimento Livre e Esclarecido/legislação & jurisprudência , Parto Normal/legislação & jurisprudência , Obstetrícia/métodos , Parto/psicologia , Gravidez , Gestantes/psicologia , Cuidado Pré-Natal/psicologia , Trauma Psicológico , Estados Unidos , Venezuela
7.
BMC Health Serv Res ; 17(1): 270, 2017 04 13.
Artigo em Inglês | MEDLINE | ID: mdl-28407765

RESUMO

BACKGROUND: The Dutch Healthcare Inspectorate supervises care providers in order to improve quality of care. Recently the inspectorate assessed and promoted the use of a guideline on smoking-cessation counselling in midwifery practices. The supervision programme consisted of an announcement of the enforcement deadline for the guideline and site visits. The purpose of our qualitative study was to identify factors related to guideline adherence after the supervision programme, and investigate whether the programme had helped improve adherence. METHODS: We conducted semi-structured interviews with inspected and non-inspected midwives. Additionally, we studied documents and observed the inspection process. The sampled midwives all work in primary care midwifery practices providing care to pregnant smokers. The questions included the current provision of smoking-cessation counselling, support to the midwife in counselling, recent changes in provision of counselling, reasons for recent changes, knowledge about the supervision programme, and experiences with supervision by the inspectorate. RESULTS: Our results show that guideline adherence depends on several factors. Awareness and familiarity with the guideline are important, as is outcome expectancy. Additionally, motivation, guideline factors and environment factors were mentioned. Besides these previously documented factors, we found that professional collaboration also determined guideline adherence. Increased collaboration in counselling is associated with greater adherence to the guideline, such as provision of counselling and taking required training. The supervision programme helped improve stop-smoking counselling, by making midwives aware of the counselling and giving them an extrinsic motivation to provide counselling. CONCLUSION: Motivation and environmental aspects were the most important factors related to guideline adherence, and professional environment was added as significant factor. The improved guideline adherence is partly attributable to the supervision programme.


Assuntos
Programas Governamentais , Fidelidade a Diretrizes , Tocologia , Cuidado Pré-Natal/métodos , Abandono do Hábito de Fumar/métodos , Fumar/efeitos adversos , Feminino , Humanos , Motivação , Países Baixos , Gravidez , Cuidado Pré-Natal/legislação & jurisprudência , Avaliação de Programas e Projetos de Saúde , Pesquisa Qualitativa , Abandono do Hábito de Fumar/legislação & jurisprudência
8.
J Health Econ ; 45: 77-90, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-26766426

RESUMO

Even though syphilis can be prevented effectively and treated inexpensively, it has remained a global public health problem. Untreated congenital syphilis results in neonatal death, stillbirth, preterm birth, or congenital deformities. Many developing countries have recently instituted syphilis prevention programs in antenatal care, but there has not been a systematic study of the effects of such programs. This paper is the first to study antenatal testing laws initiated in the U.S. in 1938-1947 which mandated physicians and other persons permitted by law to attend to a pregnant woman to test her for syphilis. We use the variation in the timing of state antenatal testing laws to estimate the laws' effect on neonatal mortality rates and deaths due to preterm birth. Using 1931-1947 Vital Statistics data, we find that these laws decreased neonatal mortality rates of nonwhites by 3.15 per 1000 live births (a 8.6% reduction) while having no discernible impact on whites. The laws contributed to an 18% narrowing of the white-nonwhite neonatal mortality gap by 1947. Using 1950 U.S. Census data, we find that mandatory antenatal testing led to a 7% increase in the cohort size of nonwhite poor, which is consistent with the neonatal mortality results. We find universal antenatal testing to be very cost-effective, with an estimated $7600 cost (in 2013 dollars) per life-year saved.


Assuntos
Mortalidade Infantil/tendências , Cuidado Pré-Natal/legislação & jurisprudência , Feminino , Humanos , Lactente , Programas de Rastreamento , Gravidez , Sífilis/diagnóstico , Estados Unidos
11.
Nutrients ; 3(3): 370-84, 2011 03.
Artigo em Inglês | MEDLINE | ID: mdl-22254102

RESUMO

Periconceptional intake of folic acid is known to reduce a woman's risk of having an infant affected by a neural tube birth defect (NTD). National programs to mandate fortification of food with folic acid have reduced the prevalence of NTDs worldwide. Uncertainty surrounding possible unintended consequences has led to concerns about higher folic acid intake and food fortification programs. This uncertainty emphasizes the need to continually monitor fortification programs for accurate measures of their effect and the ability to address concerns as they arise. This review highlights the history, effect, concerns, and future directions of folic acid food fortification programs.


Assuntos
Dieta , Ácido Fólico/uso terapêutico , Alimentos Fortificados , Defeitos do Tubo Neural/prevenção & controle , Resultado da Gravidez , Cuidado Pré-Natal , Complexo Vitamínico B/uso terapêutico , Feminino , Ácido Fólico/efeitos adversos , Ácido Fólico/história , Alimentos Fortificados/efeitos adversos , Alimentos Fortificados/história , História do Século XX , História do Século XXI , Humanos , Defeitos do Tubo Neural/história , Gravidez , Cuidado Pré-Natal/história , Cuidado Pré-Natal/legislação & jurisprudência , Complexo Vitamínico B/efeitos adversos , Complexo Vitamínico B/história
12.
Ther Drug Monit ; 32(3): 305-10, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20445484

RESUMO

The main objective of this study is to evaluate the clinical utility of meconium analysis for fatty acid ethyl esters as a universal screening tool intended for the detection of newborns at risk for fetal alcohol spectrum disorder. This will be accomplished by assessing the rate of voluntary participation in a nonanonymous neonatal screening program and by determining the logistics of implementing the necessary follow-up and interventions as part of routine care. Additionally, this study will determine the predictive value of fatty acid ethyl ester-positive meconium with regard to neurodevelopmental delays. This is an ongoing prospective cohort study. Written informed consent is sought from all Grey Bruce women delivering at participating birthing sites. Collected meconium samples are tested for fatty acid ethyl esters by headspace-solid-phase microextraction followed by gas chromatography-mass spectrometry. Children with positive results are followed up through an existing public health program involving regular home visits and assessments of developmental milestones by a public health nurse. These children and matched control subjects also undergo neurodevelopmental testing at 3 and 18 months of age by a clinical psychologist using Bayley Scales of Infant and Toddler Development. If delays are detected, the child is referred to diagnostic services and appropriate intervention programs. This study has been granted ethics approval and enrollment began in November 2008 at St. Joseph's Health Care in London, Ontario. The first positive case has been identified and the follow-up is currently being conducted by the public health unit. The successful completing of this study will reveal the population's willingness to participate in a neonatal screening program for prenatal alcohol exposure and determine the costs, feasibility, and utility of implementing such programs in clinical practice.


Assuntos
Alcoolismo/metabolismo , Etanol/toxicidade , Transtornos do Espectro Alcoólico Fetal/etiologia , Feto/efeitos dos fármacos , Programas de Rastreamento/métodos , Ésteres/análise , Ácidos Graxos/análise , Feminino , Transtornos do Espectro Alcoólico Fetal/metabolismo , Cromatografia Gasosa-Espectrometria de Massas , Unidades Hospitalares , Humanos , Lactente , Recém-Nascido , Londres , Mecônio/metabolismo , Ontário , Projetos Piloto , Gravidez , Cuidado Pré-Natal/legislação & jurisprudência , Desenvolvimento de Programas
16.
107 Emergencia ; 3(14): 10-14, mar. 2006.
Artigo em Espanhol | LILACS | ID: lil-456383

RESUMO

Se debe evitar el uso de plantas con fines terapéuticos sin un adecuado control médico, sobre todo en el período gestacional. Se distinguen las plantas adecuadas para ser utilizadas durante el embarazo, y las que son peligrosas, especialmente el cornezuelo de centeno y sus derivados


Assuntos
Cuidado Pré-Natal/legislação & jurisprudência , Cuidado Pré-Natal/tendências , Claviceps , Fitoterapia , Gravidez
17.
Asunción; Ministerio de Salud Pública y Bienestar Social; 2006. 141 p. tab, graf, ilus.
Monografia em Espanhol | LILACS, BDNPAR | ID: lil-468431
18.
Soc Sci Med ; 56(9): 1933-46, 2003 May.
Artigo em Inglês | MEDLINE | ID: mdl-12650730

RESUMO

Amniocentesis, and other prenatal genetic tests, have become a well-established feature of modern prenatal care. But these tests place a considerable decision-making burden on the expectant mothers to whom they are offered: the genetic issues involved are complex and the appropriate course of action sometimes ambiguous. Genetic counseling aims to help pregnant clients make an informed decision about prenatal genetic tests. But the clientele of prenatal genetic counseling has changed significantly in the years since the practice was established. Clients were once a self-selected group of women well-informed about the genetic services being offered. In contrast, clients now include an increasing number of women, particularly ethnic minority women, who had no prior knowledge of genetic testing, but were found to be at risk of birth defects after routine screening. Little is known about how well genetic counseling serves the needs of this new clientele. This paper investigates the possibility that miscommunication between genetic counselors and their Mexican-origin clients contributed to the higher rates of amniocentesis refusal. We interviewed 156 pregnant Mexican-origin women who screened positive on a blood test routinely offered in California to detect birth defects. We also observed the genetics consultations of a sub-sample of the women. We identified five common sources of miscommunication: (1) Medical jargon; (2) The non-directive nature of counseling; (3) The inhibitions of counselors stemming from misplaced cultural sensitivity; (4) Problems of translation; (5) Problems of trust. We found that many Mexican-origin women are skeptical of genetic testing and do not easily surrender their own lay theories about the causes of their condition. In order to dislodge the misunderstandings of their clients, counselors must give clients the opportunity to air their own views, however contrary to those of genetics professionals these may be.


Assuntos
Amniocentese/estatística & dados numéricos , Barreiras de Comunicação , Cultura , Aconselhamento Genético/psicologia , Americanos Mexicanos/psicologia , Aceitação pelo Paciente de Cuidados de Saúde/etnologia , Relações Profissional-Paciente , Antropologia Cultural , California , Anormalidades Congênitas/sangue , Anormalidades Congênitas/diagnóstico , Tomada de Decisões , Feminino , Doenças Fetais/sangue , Doenças Fetais/diagnóstico , Aconselhamento Genético/estatística & dados numéricos , Testes Hematológicos , Humanos , Masculino , Programas de Rastreamento/legislação & jurisprudência , Americanos Mexicanos/educação , Gravidez , Cuidado Pré-Natal/legislação & jurisprudência , alfa-Fetoproteínas/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA